The list of most-cited papers in breast cancer is headed by papers on tumor angiogenesis as a prognostic indicator, and reports of clinical trials for drug treatments of both late and early forms of the disease. Other topics high on the list are studies of the risks of hormone replacement therapies, and the identification of genes that appear to lead to susceptibility to breast cancer.
Methodology
To construct this database, papers were extracted based on title- and author-supplied keywords for breast cancer. The keywords used were as follows: axillary lymph node, axillary lymph nodes, breast cancer, breast cancer recurrence, breast cancers, breast carcinoma, breast carcinomas, breast neoplasm, breast
neoplasms, breast tumor, breast tumors, BRCA-1, BRCA1, BRCA1 gene, BRCA2,
DCIS, ductal carcinoma in situ, ductal carcinoma in-situ, ductal carcinoma
insitu, early breast cancer, locally advanced breast cancer, lymph node metastases, lymph node metastasis, lymph-node metastases, lymph-node metastasis, metastatic breast cancer, metastatic breast carcinoma, primary breast cancer, breast-cancer, breast-carcinoma, breast-tumors,
BRCA, and DCIS.
The baseline time span for this database was
1981-1999. The resulting database contained 40,300 papers; 67,195 authors; 117 countries; 1,819 journals; and 11,534 institutions.
Rankings
Once the database was in place, it was used to generate the lists of top 25 papers, authors, journals, institutions, and nations, covering a time span of
1991-1999.
The top 25 papers are ranked according to total cites. Rankings for author, journal, institution, and country are listed in three ways: according to total papers, total cites, and total cites/paper.
Ranking by total cites was used as the basis for determining which
author, journal, institution, and country to feature in our editorial section.
Breast
Cancer
related links:
Return to previous page
